Ultrasonic tissue characterization in predicting residual ischemia and myocardial viability for patients with acute myocardial infarction

Ultrasound Med Biol. 1998 Oct;24(8):1107-20. doi: 10.1016/s0301-5629(98)00104-5.

Abstract

The identification of viable myocardium and residual ischemia in patients with acute myocardial infarction has important prognostic implications. The ultrasonic tissue characterization with integrated backscatter and dobutamine-atropine stress echocardiography were performed 8.3+/-3 days after AMI in 30 patients. After coronary angioplasty for the residual stenosis of infarct-related artery, both modalities were repeated. The parameter obtained from ultrasonic tissue characterization, phase-weighted variation, could differentiate the myocardium with residual coronary stenosis or nonviable myocardium from the viable myocardium without residual coronary stenosis (p < 0.001). Using the cutoff value of 5.8 dB, the sensitivity, specificity and accuracy for detecting viable myocardium without residual coronary stenosis were 75%, 100% and 90.2%, respectively. The phase-weighted variation of the viable infarction zone restored after the coronary stenosis was relieved. In contrast, the nonviable myocardium had a small phase-weighted variation that was irrelevant to the patency of the infarct-related artery. The ultrasonic tissue characterization may be used in identifying patients with acute myocardial infarction whose infarction zones are viable without residual ischemia.

Publication types

  • Comparative Study

MeSH terms

  • Angioplasty
  • Atropine
  • Coronary Angiography
  • Coronary Disease / therapy
  • Dobutamine
  • Echocardiography*
  • Electrocardiography
  • Exercise Test
  • Female
  • Follow-Up Studies
  • Heart Ventricles / diagnostic imaging*
  • Heart Ventricles / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardial Infarction / diagnostic imaging*
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Thrombolytic Therapy

Substances

  • Dobutamine
  • Atropine